Case trackerActive
Tepezza use and a claim for hearing loss Updates
Updated Oct 6, 2026
Hearing changes after Tepezza? Contact your care team.
Register interestFollow the record
No source-linked updates are available here yet. The case guide has the current information and eligibility details.
Sources
- FDA-hosted Tepezza prescribing information, September 2025FDA-hosted Tepezza prescribing information, September 2025 · regulator
- Amgen Tepezza prescribing information, revised September 2026Amgen Tepezza prescribing information, revised September 2026
- Douglas et al., prospective hearing follow-up study, Thyroid 2024Douglas et al., prospective hearing follow-up study, Thyroid 2024 · study
- Van Swol et al., prospective hearing pilot, Endocrine July 15, 2026Van Swol et al., prospective hearing pilot, Endocrine July 15, 2026 · study
- Douglas et al., active thyroid-eye-disease trial, NEJM January 23, 2020Douglas et al., active thyroid-eye-disease trial, NEJM January 23, 2020 · study
- JPML Tepezza MDL 3079 transfer order, June 2, 2023JPML Tepezza MDL 3079 transfer order, June 2, 2023 · court
- Tepezza Case Management Order 1, June 13, 2023Tepezza Case Management Order 1, June 13, 2023 · court
- JPML actions pending report, October 1, 2026JPML actions pending report, October 1, 2026 · court
- ABA Model Rule 1.5 feesABA Model Rule 1.5 fees
- HHS medical records accessHHS medical records access · regulator
- SDNY filing-time FAQSDNY filing-time FAQ · court
- U.S. Courts civil cases processU.S. Courts civil cases process · court
Want the complete picture?
Read the case guide for eligibility, evidence and your next steps.